Table 5.
Covariance matrix for random effects (etas) for the final population pharmacokinetic model of vortioxetine in healthy individuals
| Parameter | ka | V2/F | CL/F |
|---|---|---|---|
| ka | 0.26 | – | – |
| V2/F | – | 0.094 | – |
| CL/F | – | 0.078 | 0.18 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.